# China SXT Pharmaceuticals, Inc. (SXTC)

> Source: Nexqual · https://nexqual.com/SXTC · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, China SXT Pharmaceuticals, Inc. (SXTC), nexqual.com/SXTC" · informational, not investment advice.

**Price:** USD 0.04 (-14.58% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 0.05 · day 0.04–0.05 · 52w 0.04–83,760 · market cap $4K · NCM

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -100.0% vs S&P 500 +13.4%; 5Y -100.0% vs S&P 500 +76.9%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -100.0% | -100.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -100.0% | -95.7% |
| Volatility (annualized) | 454.2% | 307.8% |
| Max drawdown | -100.0% (Jan 2026→Oct 2026) | -100.0% (Jun 2022→Oct 2026) |

## Peers (Drug Manufacturers - Specialty & Generic)
SUPN (Supernus Pharmaceuticals, Inc.) USD 40.7 -3.26% · BHC (Bausch Health Companies Inc.) USD 6.44 -0.77% · HCM (HUTCHMED (China) Limited) USD 14.36 +0.56% · AMLX (Amylyx Pharmaceuticals, Inc.) USD 27.2 -4.80% · RGC (Regencell Bioscience Holdings L) USD 7.67 -21.81% · LQDA (Liquidia Corporation) USD 42.65 +7.46%

## More
Full page: https://nexqual.com/SXTC · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in SXTC's own 20-F filed 2026-07-01 (https://www.sec.gov/Archives/edgar/data/1723980/000121390026074310/ea0295524-20f_chinasxt.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Jiuzhoutong Pharmaceutical | "to hospitals and other healthcare distributors such as Jiuzhoutong Pharmaceutical Co. Ltd. As of March 31, 2026, our end-customer base" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |